AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatm...
Leadership
Eric E. EasomFounder
Co-Founder, CEO, President & Chairman of the Board
Joseph S. ZakrzewskiFounder
Co-Founder & Independent Director
Lucy O. Day CPA
CFO, & Principal Financial Officer
Joshua M. Eizen J.D.
Chief Legal Officer, COO & Corporate Secretary
George Harrison Talbot FACP, M.D.Founder
Co-Founder & Senior Clinical Advisor
Michael R. K. Alley Ph.D.Founder
Co-Founder, Senior VP of Research Fellow & Head of Biology
Sarah Williams
Vice President of Controller & Principal Accounting Officer
